RXMD:OTO-Progressive Care Inc (USD)

COMMON STOCK | Pharmaceutical Retailers | OTC Pink

Last Closing

USD 1.933

Change

+0.16 (+9.21)%

Market Cap

USD 3.46M

Volume

1.10K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Progressive Care Inc provides prescription pharmaceuticals specializing in health practice risk management, compounded medications, sale of anti-retroviral medications, medication therapy management & supply of prescription medications to facilities.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
JDHIY JD Health International Inc

N/A

USD 10.21B
JDHIF JD Health International Inc

N/A

USD 9.97B
RADLY Raia Drogasil SA ADR

+0.20 (+4.35%)

USD 8.83B
ALBHF Alibaba Health Information Tec..

+0.01 (+2.17%)

USD 6.48B
CLCGY Clicks Group Ltd

-0.05 (-0.11%)

USD 5.41B
SAEYY Shop Apotheke Europe N.V

+1.66 (+13.24%)

USD 2.73B
SHPPF Shop Apotheke Europe N.V

N/A

USD 2.67B
ZRSEF Zur Rose Group AG

N/A

USD 0.68B
NOTR Nowtransit Inc

N/A

USD 0.55B
NVACF Nova Cannabis Inc

-0.01 (-0.47%)

USD 0.08B

ETFs Containing RXMD

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -38.44% 29% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -38.44% 29% F 22% F
Trailing 12 Months  
Capital Gain -56.56% 22% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -56.56% 22% F 19% F
Trailing 5 Years  
Capital Gain -77.52% 47% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -77.52% 47% F 26% F
Average Annual (5 Year Horizon)  
Capital Gain 47.51% 67% D+ 76% C+
Dividend Return 47.51% 67% D+ 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 699.46% 26% F 12% F
Risk Adjusted Return 6.79% 44% F 41% F
Market Capitalization 3.46M 57% F 41% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative earnings

The company had negative total earnings in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.